If you don't have access to any of the email addresses linked to your account, click the No longer have access to these? link under the list of email addresses. Follow the directions provided to answer your security question and regain access to your account.
Adamis Pharmaceuticals Corp trades on the NASDAQ under the ticker symbol ADMP.. 2 brokerages have issued 12-month target prices for Adamis Pharmaceuticals Corp's shares. Their forecasts range from $5.00 to $10.00. On average, they expect Adamis Pharmaceuticals Corp's stock price to reach $7.50 in the next year.
Initiating coverage on Cempra with a Buy rating and common stock price target of $22.44. The stock has pulled back from its 2015 highs and might see upward movement after FDA acceptance of an NDA application for Solithromycin in adult community-acquired bacterial pneumonia.